Fig. 7: Dectin-1 Antagonist Laminarin treatment reversed the deteriorated effect of C. albicans and CAG on HFD-treated mice.
From: Abnormal proliferation of gut mycobiota contributes to the aggravation of Type 2 diabetes
Effects of Laminarin on C. albicans induced metabolic disorders. a Body Weight, b Fasted blood glucose, c ITT on the 31th day, d OGTT and e AOC on the 34th day, f HOMA-IR, g HbA1c. Effects of Laminarin on CAG induced metabolic disorders. h Body Weight, i Fasted blood glucose, j ITT on the 31th day, k OGTT and l AOC on the 34th day, m HOMA-IR, n HbA1c. Data are presented as the mean ± standard error of the mean (SEM); n = 9 mice per group. Statistical analysis was done using one-way ANOVA followed by the Tukey post hoc test. *P < 0.05; **P < 0.01 and ***P < 0.001vs HFD-CA (CAG) group, and #P < 0.05; ##P < 0.01 vs HFD-WT group.
